Saxagliptin
These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009
f3ea58bb-0002-4a5d-9213-7e9066e3dc9c
HUMAN PRESCRIPTION DRUG LABEL
Jan 9, 2024
Aurobindo Pharma Limited
DUNS: 650082092
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Saxagliptin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
Saxagliptin
Product Details
FDA regulatory identification and product classification information